Swiss National Bank’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Swiss National Bank’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,700	Closed	-$71K	–	2539
2018 Q1	$71K	Hold	6,700	–	–	﹤0.01%	2482
2017 Q4	$282K	Hold	6,700	–	–	﹤0.01%	2496
2017 Q3	$369K	Hold	6,700	–	–	﹤0.01%	2447
2017 Q2	$1.24M	Buy	6,700 +1,000	+18%	+$175K	﹤0.01%	1902
2017 Q1	$681K	Hold	5,700	–	–	﹤0.01%	2246
2016 Q4	$566K	Hold	5,700	–	–	﹤0.01%	2336
2016 Q3	$638K	Sell	5,700 -475	-8%	-$57K	﹤0.01%	2230
2016 Q2	$634K	Hold	6,175	–	–	﹤0.01%	2223
2016 Q1	$551K	Buy	6,175 +937	+18%	+$100K	﹤0.01%	2253
2015 Q4	$755K	Buy	+5,238	New	+$682K	﹤0.01%	2009

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss National Bank's SIOX Position: Q2 2018 in Review

Swiss National Bank sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 6,700 shares — an estimated $71K sold.

Swiss National Bank first reported a position in SIOX in Q4 2015 and held it in 10 quarters. The position peaked at $1.24M in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

Swiss National Bank reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Swiss National Bank sold 6,700 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $71K.
Swiss National Bank first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 10 quarters.
Swiss National Bank's Sio Gene Therapies Inc. Common Stock position peaked at $1.24M in Q2 2017.
71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Swiss National Bank's 13F filing for Q2 2018, filed 9 Aug 2018.